Novo Nordisk A/S

Healthcare · Drug Manufacturers - General

38.70$ -0.2% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Novo Nordisk A/S (NVO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 542,902 million DKK. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of DKK.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NVO
Line item	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	77,062	91,799	97,539	102,355	110,769	18,869	23,822	194,508	241,257	314,486	465,795	542,902
Current Assets	46,293	55,140	59,766	60,080	59,067	9,382	10,818	85,595	108,194	139,646	160,897	172,453
Cash	14,396	16,923	18,690	18,852	15,638	2,325	2,097	10,720	12,653	14,392	15,655	26,464
Cash & Short-Term Investments	15,905	20,465	20,699	18,852	15,638	2,325	2,097	17,485	23,574	30,230	26,308	26,962
Receivables	15,791	17,742	24,197	23,551	26,889	3,863	4,606	46,799	57,505	75,261	87,414	75,697
Inventory	11,357	12,758	14,341	15,373	16,336	2,650	3,047	19,621	24,388	31,811	40,849	49,623
Property, Plant & Equipment	3,760	25,545	30,179	35,247	41,891	50,551	50,269	55,362	66,671	90,961	162,488	208,378
Goodwill	–	0.0	0.0	0.0	0.0	0.0	0.0	4,346	5,092	4,464	20,064	19,845
Intangible Assets	1,378	2,158	2,714	3,325	5,145	877	3,396	38,825	46,324	55,942	91,026	110,208
Total Liabilities	36,768	44,830	52,270	52,540	58,930	10,218	13,413	123,762	157,771	207,925	322,309	348,855
Current Liabilities	33,689	40,873	47,436	47,056	54,164	8,860	11,551	99,516	120,940	169,655	217,528	215,661
Short-Term Debt	720	1,073	229	1,694	515	221	1,226	13,684	1,466	6,478	13,113	12,017
Accounts Payable	4,950	4,927	6,011	5,610	6,756	955	940	8,870	15,587	25,606	28,846	19,758
Long-Term Debt	–	0.0	0.0	0.0	0.0	0.0	–	9,654	20,775	15,976	84,246	118,941
Shareholders' Equity	40,294	46,969	45,269	49,815	51,839	8,651	10,409	70,746	83,486	106,561	143,486	194,047
Retained Earnings	41,277	46,816	46,111	48,977	53,406	8,685	10,483	72,004	80,587	104,839	144,448	195,298
Shares Outstanding	5,260	5,157	5,070	4,956	4,849	4,757	4,680	4,606	4,545	4,495	4,463	4,448

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings